Dr. Reddy's Laboratories Ltd. share price logo

Dr. Reddy's Laboratories Ltd. Share Price

NYSE: RDY

Large Cap

$14.63

-0.03

(-0.17%)

as on

Dr. Reddy's Laboratories Ltd. Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $14.6
    $14.8
    downward going graph

    0.21%

    Downside

    1.16%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.26
    $16.19
    downward going graph

    16.20%

    Downside

    10.68%

    Upside

    downward going graph

Dr. Reddy's Laboratories Ltd. share price movements today

Previous Close
$14.66
Open
$14.80
Volume
724.0K
Day's Low - High
$14.6 - $14.8
52 Week Low - High
$12.26 - $16.19

Dr. Reddy's Laboratories Ltd. Historical Returns

1 Month Return
+ 3.09 %
3 Month Return
-7.22 %
1 Year Return
-8.8 %
3 Year Return
+ 41.75 %
5 Year Return
+ 21.18 %

Dr. Reddy's Laboratories Ltd. Stock Fundamentals & Key Indicators

Check Dr. Reddy's Laboratories Ltd. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$12.4B

EPS (TTM)

70.93

Dividend Yield

0.58%

Quarterly Earnings Growth YOY

0.02%

PE Ratio (TTM)

19.04

Industry PE ratio

16.65525641025641

P/B Ratio

19.039

PEG Ratio

3.2524

EBITDA

89.4B

Revenue (TTM)

334.3B

Profit Margin

16.99%

Return On Equity TTM

17.71%

Dr. Reddy's Laboratories Ltd. Stock Valuation

Track how Dr. Reddy's Laboratories Ltd. P/E has moved over time to understand its valuation trends.

Dr. Reddy's Laboratories Ltd. in the last 5 years

  • Overview

  • Trends

Lowest (0.04x)

June 30, 2024

Industry (16.66x)

September 15, 2025

Today (19.04x)

September 15, 2025

Highest (8.91x)

June 30, 2021

LowHigh

Today’s Price to Earnings Ratio: 19.04x

Dr. Reddy's Laboratories Ltd. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dr. Reddy's Laboratories Ltd. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$12.4B21.18%19.0416.99%
BUY$18.3BNA15.840.36%
BUY$44.1BNA21.813.81%
BUY$14.1B36.02%41.9713.88%
BUY$65.7B-8.68%25.5127.83%

Stock Returns calculator for Dr. Reddy's Laboratories Ltd. Stock including INR - Dollar returns

The Dr. Reddy's Laboratories Ltd. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Dr. Reddy's Laboratories Ltd. investment value today

Current value as on today

₹96,025

Returns

₹3,975

(-3.98%)

Returns from Dr. Reddy's Laboratories Ltd. Stock

₹8,961 (-8.96%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Dr. Reddy's Laboratories Ltd. Stock

Based on 40 analysts

BUY

42.50%

Buy

30.00%

Hold

27.50%

Sell

Based on 40 analysts, 42.5% of analysts recommend a 'BUY' rating for Dr. Reddy's Laboratories Ltd.. Average target price of $15.17

Dr. Reddy's Laboratories Ltd. Share Price Target

Get share price movements and forecasts by analysts on Dr. Reddy's Laboratories Ltd..

What analysts predicted

3.56%UPSIDE

Target Price

$15.17

Current Price

$14.63

Analyzed by

40 Analysts

Target

$15.17

Dr. Reddy's Laboratories Ltd. target price $15.17, a slight upside of 3.56% compared to current price of $14.63. According to 40 analysts rating.

Dr. Reddy's Laboratories Ltd. Stock's Interest Amongst Investors

Investment in Dr. Reddy's Laboratories Ltd. Shares on INDmoney has dropped by -35.29% over the past 30 days, indicating reduced transactional activity.

Time period: to

Change:-35.29% versus previous 30 day period

Search interest for Dr. Reddy's Laboratories Ltd. Stock has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-44% versus previous 30 day period

Dr. Reddy's Laboratories Ltd. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
765
820
828
866
852
919
956
983
983
85,452
Gross Profit
628
481
486
506
499
555
570
577
546
48,627
Operating Income
21,952
17,636
17,867
17,267
14,786
17,925
17,551
18,720
17,647
17,475
EBITDA
16,798
21,224
20,290
21,286
18,499
21,757
23,899
24,279
25,264
24,642
Interest Expense
354
371
353
394
593
598
757
818
656
830
Depreciation
3,055
3,569
3,789
3,770
3,713
3,810
3,975
4,719
4,554
4,765
Income Before Tax
13,291
18,463
19,134
18,257
16,016
18,821
19,167
18,742
20,054
19,047
Income Tax Expense
3,690
4,438
4,334
4,468
2,946
4,901
5,752
4,704
4,182
4,951
Net Income
116
170
178
165
157
166
149
166
184
14,178
Net Profit Margin
15.23%
20.81%
21.51%
19.11%
18.45%
18.14%
15.66%
16.91%
18.74%
16.59%

Dr. Reddy's Laboratories Ltd. Annual Profit & Loss

All numbers in Millions USD

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Total Revenue
2,309
2,138
2,184
2,207
2,340
2,604
2,813
2,989
3,361
3,763
Gross Profit
1,377
1,189
1,173
1,196
1,260
1,415
1,493
2,468
1,970
2,201
Operating Income
29,619
13,498
11,917
20,888
37,055
36,062
40,818
96,282
67,729
71,843
EBITDA
39,869
24,775
23,627
31,865
41,785
45,706
47,743
74,431
88,422
96,671
Interest Expense
826
634
788
889
983
970
958
1,428
1,711
2,829
Depreciation
-
-
11,710
12,190
12,472
12,796
11,824
12,502
14,841
17,058
Income Before Tax
27,140
14,653
14,341
22,443
18,032
28,324
32,298
60,485
71,870
76,784
Income Tax Expense
7,127
2,614
4,535
3,648
-1,466
9,175
8,730
15,412
16,186
19,539
Net Income
298
182
150
269
261
236
309
548
670
653
Net Profit Margin
12.94%
8.55%
6.90%
12.22%
11.17%
9.09%
10.99%
18.33%
19.95%
17.37%

Dr. Reddy's Laboratories Ltd. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
14,025
14,800
13,789
13,070
13,920
13,415
14,038
15,872
14,096
Operating Cash Flow
11,250
17,926
4,737
11,520
8,496
9,316
6,620
21,996
14,629
Investing Cash Flow
-8,236
-12,753
-
-11,350
-20,248
-19,071
-5,458
-13,300
-19,192
Financing Cash Flow
-1,476
-7,036
5,282
-533
9,541
16,150
590
-7,370
-1,203
Change in Cash
1,449
6,307
-6,000
-428
-2,194
6,372
1,747
1,561
-5,589

Dr. Reddy's Laboratories Ltd. Annual Cash Flow

All numbers in Millions USD

Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Net Income
12,039
9,806
18,795
19,498
19,149
23,568
60,485
55,684
57,245
Operating Cash Flow
21,513
18,029
28,704
29,841
35,703
28,108
58,873
45,433
46,428
Investing Cash Flow
-18,471
-14,883
-7,727
-4,923
-22,660
-26,387
-41,373
-40,283
-58,077
Financing Cash Flow
-3,692
-4,440
-21,326
-25,159
-298
-2,422
-26,861
-3,763
18,911
Change in Cash
-1,142
-1,237
-314
-266
12,858
32
-9,073
1,328
7,486

Global Institutional Holdings in Dr. Reddy's Laboratories Ltd.

Funds
Holdings
Robeco Institutional Asset Management BV
1.46%
Renaissance Technologies Corp
1.1%
Royal Bank of Canada
1.09%
Morgan Stanley - Brokerage Accounts
1.05%
BlackRock Inc
1.02%

Insights on Dr. Reddy's Laboratories Ltd.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 6 quarters, 70.83B → 85.45B (in $), with an average increase of 3.7% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, United Therapeutics Corporation has given 85.7% return, outperforming this stock by 40.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, United Therapeutics Corporation has given 17.4% return, outperforming this stock by 25.4%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 15.93B → 14.17B (in $), with an average decrease of 11.0% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, RDY stock has moved down by -6.7%

About Dr. Reddy's Laboratories Ltd.

"Dr. Reddy's Laboratories is a global pharmaceutical company headquartered in Hyderabad, Telangana, India. Founded in 1984 by Dr. K. Anji Reddy, the company provides a wide range of pharmaceuticals in India and over 25 countries worldwide. Dr. Reddy's Laboratories operates in various segments, including generic medicines, active pharmaceutical ingredients (APIs), custom pharmaceutical services, biosimilars, and differentiated formulations. The company's portfolio includes products for therapeutic areas such as gastroenterology, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy's Laboratories is listed on the NYSE under the ticker symbol RDY, making its American Depositary Receipts (ADRs) available to U.S. investors. Known for its commitment to innovation, quality, and affordability, Dr. Reddy's Laboratories continues to deliver comprehensive healthcare solutions and improve the lives of patients globally. Currently Dr. Reddy's Laboratories ADR has a market cap of $12.41 Billion. It has a P.E ratio of 19.04. The shares of Dr. Reddy's Laboratories ADR are trading at {current share price in dollars (in INR)}"
OrganisationDr. Reddy's Laboratories Ltd.
Headquarters8-2-337, Road No. 3, Hyderabad, India, 500034
IndustryHealth Technology
CEOMr. Erez Israeli M.B.A.
E-voting on sharesClick here to vote

Key Management of Dr. Reddy's Laboratories Ltd.

Name

Title

Mr. Deepak Sapra M.B.A.

Global Head of Pharmaceutical Services and Active Ingredients & Member of Management Council

Ms. Archana Bhaskar B.Sc., M.B.A.

EVP, Head of Corporate Communications, Chief Human Resources Officer & Member of Management Council

Mr. Sanjay Sharma B.Tech.

Executive VP, Global Head of Global Manufacturing & Member of Management Council

Mr. Gunupati Venkateswara Prasad B.E.

Co-Chairman, MD & Member of Management Council

Mr. Erez Israeli M.B.A.

CEO & Member of the Management Council

Mr. Mannam Venkatanarasimham

CFO & Member of the Management Council

Mr. Krishna K. Venkatesh B.Pharma M.S.

Global Head of Quality and Pharmacovigilance & Member of the Management Council

Mr. Motupalli Venkata Ramana M.B.A.

CEO of Branded Markets - India & Emerging Countries and Member of Management Council

Mr. Patrick Aghanian B.A., M.B.A.

Head of Generics, Europe & Consumer Health and Member of Management Council

Mr. Kallam Satish Reddy B.Tech., M.S.

Chairman of the Board & Member of the Management Council

FAQs

What is Dr. Reddy's Laboratories Ltd. share price today?

Dr. Reddy's Laboratories Ltd. share price today is $14.63 as on at the close of the market. Dr. Reddy's Laboratories Ltd. share today touched a day high of $14.8 and a low of $14.6.

What is the 52 week high and 52 week low for Dr. Reddy's Laboratories Ltd. share?

Dr. Reddy's Laboratories Ltd. share touched a 52 week high of $16.19 on and a 52 week low of $12.26 on . Dr. Reddy's Laboratories Ltd. stock price today i.e. is closed at $14.63,which is 9.65% down from its 52 week high and 19.33% up from its 52 week low.

What is Dr. Reddy's Laboratories Ltd.'s market capitalisation today?

Dr. Reddy's Laboratories Ltd. market capitalisation is $0.01T as on .

How to invest in Dr. Reddy's Laboratories Ltd. Stock (RDY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dr. Reddy's Laboratories Ltd. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dr. Reddy's Laboratories Ltd. Shares that will get you 0.1025 shares as per Dr. Reddy's Laboratories Ltd. share price of $14.63 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Dr. Reddy's Laboratories Ltd. Stock (RDY) from India?

Indian investors can start investing in Dr. Reddy's Laboratories Ltd. (RDY) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Dr. Reddy's Laboratories Ltd. stock (as per the Rupee-Dollar exchange rate as on ). Based on Dr. Reddy's Laboratories Ltd. share’s latest price of $14.63 as on September 16, 2025 at 1:29 am IST, you will get 0.6835 shares of Dr. Reddy's Laboratories Ltd.. Learn more about fractional shares .

What are the returns that Dr. Reddy's Laboratories Ltd. has given to Indian investors in the last 5 years?

Dr. Reddy's Laboratories Ltd. stock has given 21.18% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?